Equity Pricing in the Real World: Moving from Ambiguity to Action for Patients, Payers, and Health Systems Aligning equitable access and commercial sustainability is one of the Read More »
Price Your Asset Right How developing an early payer value story and value messages supported a differentiated offer within neurology, covering multiple possible scenarios at global and regional levels Read More
Define Your Value Strategy How i-vbp® enabled the identification of the disease attractiveness and key value metrics to support a product’s indication prioritization strategy Read More
Define Your Value Strategy How a thorough analysis of potential access scenarios allowed the successful launch of a new product indication Read More
Optimize your evidence plan How developing and testing of a value narrative with payers formed the foundation for a strong early market access strategy Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the clinical development plan and market access strategy for a novel drug in PD Read More
Optimize your evidence plan How synthesizing multiple perspectives has enabled the refinement of the market access strategy for four novel cell therapies Read More
